HealthIT Answers November 8, 2021
Industry Expert

By Jeff Shuren, M.D., J.D., Director, Center for Devices and Radiological Health (CDRH) and William Maisel, M.D., MPH, Director, Office of Product Evaluation and Quality (OPEQ), CDRH, FDA

At the U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH), we are committed to protecting the public health by ensuring patients have more timely access to safe, effective, and high-quality medical devices. This includes our responsibility to review premarket submissions for certain new medical devices and modifications to devices currently on the market. As part of this ongoing work, the FDA continues to take steps to strengthen the premarket review program and make it more efficient, consistent, and predictable.

While the pandemic has challenged CDRH in many ways, it has also...

Today's Sponsors

Patient Bond
Institute for Healthcare Improvement

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsor

Patient Bond

Topics: FDA, Govt Agencies, Medical Devices
Venture capital firm launches $75M telehealth-focused fund
It’s Time to Go Digital with Your Payments: Here’s Why
Big Health’s Softbank Money, FDA Board Member Send Strong Signals About Digital Therapeutics Market
URAC CEO talks virtual care access, tele-mental health, post-COVID regs
Telemedicine 2022